Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% | -.--% | -100.00% |
May. 06 | Motion for Asset Sale Filed by MedAvail Holdings, Inc. | CI |
May. 03 | Notice of Successful Bidder Filed by MedAvail Holdings, Inc. | CI |
Financials (USD)
Sales 2021 | 22.13M | Sales 2022 | 43.11M | Capitalization | 24M |
---|---|---|---|---|---|
Net income 2021 | -43M | Net income 2022 | -47M | EV / Sales 2021 | 1.74 x |
Net cash position 2021 | 7.44M | Net cash position 2022 | 4.37M | EV / Sales 2022 | 0.46 x |
P/E ratio 2021 |
-1.04
x | P/E ratio 2022 |
-0.41
x | Employees | 279 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.6% |
Latest transcript on MedAvail Holdings, Inc.
3 months | -99.99% | ||
6 months | -99.99% | ||
Current year | -100.00% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Doerr
CEO | Chief Executive Officer | 54 | 22-01-09 |
Ramona Seabaugh
DFI | Director of Finance/CFO | 55 | 21-09-19 |
Will Misloski
SAM | Sales & Marketing | 53 | 18-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Laurie McGraw
BRD | Director/Board Member | 60 | 22-01-09 |
Glen D. Stettin
BRD | Director/Board Member | 60 | 20-11-17 |
Robert Faulkner
CHM | Chairman | 61 | 20-11-17 |
1st Jan change | Capi. | |
---|---|---|
-100.00% | 322 | |
+18.47% | 88.33B | |
+18.53% | 70.19B | |
+24.49% | 38.84B | |
+26.97% | 35.2B | |
+9.77% | 27.82B | |
+11.60% | 27.49B | |
+4.67% | 27.13B | |
+21.94% | 25.78B | |
+6.82% | 23.89B |
- Stock Market
- Equities
- MYOS Stock